Clinical Trials Update: Nov. 19, 2010

Clinical Trials Update: Nov. 19, 2010 (HealthDay News) — Here are the latest clinical trials, courtesy of ClinicalConnection.com: Read more on HealthDay via Yahoo! News Phase 2 Study of Eculizumab (Soliris®) in Patients with aHUS Resistant to Plasma Therapy Met Primary and Secondary … Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today that a Phase 2 clinical study investigating Soliris ® (eculizumab)...

Rapid And Long-term Clinical Responses Observed In...

Rapid And Long-term Clinical Responses Observed In Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab Pegol) Cimzia® (certolizumab pegol) data demonstrating rapid and sustained improvements in managing moderate to severe rheumatoid arthritis (RA) symptoms, reducing disease activity and inhibiting joint damage progression will be exhibited during the American College of Rheumatology’s 2010 Annual Scientific...